The impact of investing in stem cell research will be the topic at thenext Lincoln Science Caf at 7 p.m. on April 13.

C. Randal Mills, Ph.D., president and CEO of the California Institute for Regenerative Medicine, will speak at Vega, 350 Canopy St. Prior to joiningthe institutein 2014, Mills was president and CEO of Osiris Therapeutics Inc., a biotechnology company specializing in stem cell science.

Under his leadership, Osiris developed the worlds first approved stem cell drug, remestemcel-L, to treat graft versus host disease in children, a devastating complication of bone marrow transplantation that can be fatal.

Science Cafsare face-to-face conversations with a scientist on a current topic. They are open to people21 and older, and take place in casual settings like pubs and coffeehouses. A scientist gives a brief presentation followed by a question-and-answer period.

For more information about Science Cafes, go to unmc.edu/sciencecafe. Podcasts of previous Science Cafes also are available on the website or available for download on iTunes.

Read the original:
Stem cell research is focus of April 13 Lincoln Science Caf